Somjot S Brar

Summary

Publications

  1. ncbi Incidence, mortality, and racial differences in peripartum cardiomyopathy
    Somjot S Brar
    Kaiser Permanente, Los Angeles, California, USA
    Am J Cardiol 100:302-4. 2007
  2. ncbi Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data
    Somjot S Brar
    Kaiser Permanente, Regional Cardiac Cath Lab, 4867 Sunset Boulevard, Los Angeles, CA 90027, USA
    J Am Coll Cardiol 58:1945-54. 2011
  3. ncbi Decision-making: stenting in acute myocardial infarction
    Somjot S Brar
    Regional Cardiac Catheterization Laboratory, 4867 Sunset Blvd, 3rd Floor, Room 3755, Kaiser Permanente Medical Center, Los Angeles, CA 90027, USA
    Future Cardiol 6:301-14. 2010
  4. ncbi Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials
    Somjot S Brar
    Columbia University Medical Center, New York, NY, USA
    EuroIntervention 5:475-84. 2009
  5. ncbi Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY 10032, USA
    Clin J Am Soc Nephrol 4:1584-92. 2009
  6. ncbi Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
    J Am Coll Cardiol 53:1677-89. 2009
  7. ncbi Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Ave, Fifth Floor, New York, NY 10032, USA
    JAMA 300:1038-46. 2008
  8. ncbi Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
    J Am Coll Cardiol 51:2220-7. 2008
  9. ncbi Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation
    Albert Yuh Jer Shen
    Department of Cardiology, Kaiser Permanente Medical Center, 1526 Edgemont St, 2nd Floor, Los Angeles, California 90027, USA
    Stroke 39:2736-43. 2008
  10. ncbi Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation
    Albert Yuh Jer Shen
    Department of Cardiology, Kaiser Permanente Medical Center, Los Angeles, California 90027, USA
    CNS Drugs 22:815-25. 2008

Detail Information

Publications15

  1. ncbi Incidence, mortality, and racial differences in peripartum cardiomyopathy
    Somjot S Brar
    Kaiser Permanente, Los Angeles, California, USA
    Am J Cardiol 100:302-4. 2007
    ..Our findings also suggest that the current mortality associated with PC may be less than reported in older series, perhaps because of the high utilization of modern HF therapy...
  2. ncbi Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data
    Somjot S Brar
    Kaiser Permanente, Regional Cardiac Cath Lab, 4867 Sunset Boulevard, Los Angeles, CA 90027, USA
    J Am Coll Cardiol 58:1945-54. 2011
    ....
  3. ncbi Decision-making: stenting in acute myocardial infarction
    Somjot S Brar
    Regional Cardiac Catheterization Laboratory, 4867 Sunset Blvd, 3rd Floor, Room 3755, Kaiser Permanente Medical Center, Los Angeles, CA 90027, USA
    Future Cardiol 6:301-14. 2010
    ..Reduced ischemic and hemorrhagic complications from new antithrombin and antiplatelet agents have further reduced mortality and improved event-free survival after primary PCI...
  4. ncbi Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials
    Somjot S Brar
    Columbia University Medical Center, New York, NY, USA
    EuroIntervention 5:475-84. 2009
    ....
  5. ncbi Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY 10032, USA
    Clin J Am Soc Nephrol 4:1584-92. 2009
    ..The aim of this study was to assess the effectiveness of hydration with sodium bicarbonate for the prevention of contrast-induced acute kidney injury (CI-AKI)...
  6. ncbi Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
    J Am Coll Cardiol 53:1677-89. 2009
    ..A secondary analysis was performed among registry studies...
  7. ncbi Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Ave, Fifth Floor, New York, NY 10032, USA
    JAMA 300:1038-46. 2008
    ....
  8. ncbi Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
    J Am Coll Cardiol 51:2220-7. 2008
    ..The purpose of this study was to determine whether long-term clinical outcomes differed between bare-metal stents (BMS) and drug-eluting stents (DES) by duration of clopidogrel use among diabetic patients...
  9. ncbi Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation
    Albert Yuh Jer Shen
    Department of Cardiology, Kaiser Permanente Medical Center, 1526 Edgemont St, 2nd Floor, Los Angeles, California 90027, USA
    Stroke 39:2736-43. 2008
    ..Warfarin reduces stroke risk in studies of predominantly white patients with atrial fibrillation (AF). Whether nonwhites also have lower rates of stroke while treated with warfarin is unclear...
  10. ncbi Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation
    Albert Yuh Jer Shen
    Department of Cardiology, Kaiser Permanente Medical Center, Los Angeles, California 90027, USA
    CNS Drugs 22:815-25. 2008
    ..Whether the same net clinical benefit extends to persons of colour is unproven. Given the rapidly changing demographic nationally and internationally, additional research is needed to resolve this important question...
  11. ncbi Discontinuation of long-term clopidogrel therapy is associated with death and myocardial infarction after saphenous vein graft percutaneous coronary intervention
    Amit Sachdeva
    Department of Cardiology, Kaiser Permanente, Los Angeles, CA 90027, USA
    J Am Coll Cardiol 60:2357-63. 2012
    ..This study sought to examine the pattern of death and myocardial infarction (MI) after clopidogrel cessation in patients undergoing percutaneous coronary intervention (PCI) of the saphenous vein graft (SVG)...
  12. ncbi Racial/ethnic differences in the prevalence of atrial fibrillation among older adults--a cross-sectional study
    Albert Yuh Jer Shen
    Department of Cardiology and the Center for Medical Education and Research, Kaiser Permanente Medical Center, Los Angeles, California 90027, USA
    J Natl Med Assoc 102:906-13. 2010
    ..This study was undertaken to define racial/ethnic differences in atrial fibrillation prevalence among a large community cohort...
  13. ncbi Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
    Albert Yuh Jer Shen
    Department of Cardiology and the Center for Medical Education, Kaiser Permanente Medical Center, Los Angeles, California 90027, USA
    J Am Coll Cardiol 50:309-15. 2007
    ..This study was designed to study racial/ethnic differences in the risk for intracranial hemorrhage (ICH) and the effect of warfarin on ICH risk among patients with atrial fibrillation (AF)...
  14. ncbi Advances in percutaneous coronary intervention
    Somjot S Brar
    Columbia University Medical Center, The Cardiovascular Research Foundation, New York, NY 10022, USA
    Curr Cardiol Rep 11:245-51. 2009
    ..An extensive evidence base of randomized clinical trials has established PCI as an important strategy with a pivotal role in the management of patients with coronary artery disease...
  15. ncbi Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
    Angiology 59:83S-8S. 2008
    ..In this article, we review the existing literature and discuss future directions in the management of the patient with multivessel disease...